CMS creating database for agencies ready to receive data

Beth Walsh | | Health Exec | Precision Medicine
The Centers for Medicare & Medicaid Services plans to create a centralized database to help providers determine public health agencies and registries' readiness to receive patient data from certified EHRs. The agency issued a notice of the plan in the Feb. 7 Federal Register, which also invited the public to comment.

Both Stages 1 and 2 of the Meaningful Use program contain objectives and measures that require providers to determine the readiness of public agencies and registries to receive the data. CMS received many comments about the unduly burden of the requirements and agreed to create a single database to serve as the definitive source for providers to use in order to eliminate the need for multiple individual inquires. The database will be located on CMS' website.

Comments are due to CMS by April 8.

Access the notice.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.